Lipopolysaccharide‐Induced Sickness Behaviour Evaluated in Different Models of Anxiety and Innate Fear in Rats
Abstract: The fact that there is a complex and bidirectional communication between the immune and nervous systems has been well demonstrated. Lipopolysaccharide (LPS), a component of gram‐negative bacteria, is widely used to systematically stimulate the immune system
and generate profound physiological and behavioural changes, also known as ‘sickness behaviour’ (e.g. anhedonia, lethargy, loss of appetite, anxiety, sleepiness). Different ethological tools have been used to analyse the behavioural modifications induced by LPS; however, many researchers
analysed only individual tests, a single LPS dose or a unique ethological parameter, thus leading to disagreements regarding the data. In the present study, we investigated the effects of different doses of LPS (10, 50, 200 and 500 μg/kg, i.p.) in young male Wistar rats (weighing 180–200 g;
8–9 weeks old) on the ethological and spatiotemporal parameters of the elevated plus maze, light‐dark box, elevated T maze, open‐field tests and emission of ultrasound vocalizations. There was a dose‐dependent increase in anxiety‐like behaviours caused
by LPS, forming an inverted U curve peaked at LPS 200 μg/kg dose. However, these anxiety‐like behaviours were detected only by complementary ethological analysis (stretching, grooming, immobility responses and alarm calls), and these reactions seem to be a very sensitive tool
in assessing the first signs of sickness behaviour. In summary, the present work clearly showed that there are resting and alertness reactions induced by opposite neuroimmune mechanisms (neuroimmune bias) that could lead to anxiety behaviours, suggesting that misunderstanding data could occur
when only few ethological variables or single doses of LPS are analysed. Finally, it is hypothesized that this bias is an evolutionary tool that increases animals’ security while the body recovers from a systemic infection.
Document Type: Research Article
Department of Physics and Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto of the University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil
Publication date: April 1, 2012
More about this publication?